Home › NDC Lookup › RxCUI directory › RxCUI 759006

Prussian blue insoluble 500 MG Oral Capsule — RxCUI 759006

RxNorm drug concept · Semantic clinical drug
RxCUI 759006 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI759006
Official namePrussian blue insoluble 500 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprussian blue 500 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Prussian blue insoluble 500 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Prussian blue insoluble 500 MG Oral Capsule RxCUI 759006

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Prussian blue insoluble 24902
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Radiogardase 539398
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Prussian blue insoluble Oral Capsule 759005
    • Prussian blue insoluble Oral Product 1162963
    • Prussian blue insoluble Pill 1162964
    • Prussian blue insoluble Oral Capsule [Radiogardase] 759008
    • Radiogardase Oral Product 1177680
    • Radiogardase Pill 1177681
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Prussian blue insoluble 500 MG SCDC · 759004
  • Prussian blue insoluble Oral Capsule SCDF · 759005
  • Prussian blue insoluble Oral Product SCDG · 1162963
  • Prussian blue insoluble Pill SCDG · 1162964

Brand-Name Concepts

  • Prussian blue insoluble 500 MG Oral Capsule [Radiogardase] SBD · 759009
  • Prussian blue insoluble 500 MG [Radiogardase] SBDC · 759007
  • Prussian blue insoluble Oral Capsule [Radiogardase] SBDF · 759008
  • Radiogardase Oral Product SBDG · 1177680
  • Radiogardase Pill SBDG · 1177681
  • Radiogardase BN · 539398

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 759006 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58060-0002-02 1 BOTTLE, PLASTIC in 1 CARTON (58060-002-02) / 36 CAPSULE i... Radiogardase Heyl Chem.-pharm. Fabrik GmbH & Co. KG 2010-03-24
Observed labelers: Heyl Chem.-pharm. Fabrik GmbH & Co. KG (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.